COMP <GO>
TDOC vs USPH // EV/EBITDA & P/E VALUATION
Teladoc Health Inc. (NYSE) VS. U.S. Physical Therapy Inc. (NYSE) • 15-METRIC TALLY: TDOC 3
— USPH 8
■ METRIC PARITY
LAST: $8.73 (+26.89%) • MKT CAP: $1.59B
valuation
—
LAST: $86.57 (+1.47%) • MKT CAP: $1.29B
valuation
16.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TDOC VS. USPH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TDOC | USPH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 19.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -17.00% | 11.50% | -28.50 | USPH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 16.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 18.00% | 5.81% | +12.19 | TDOC | /fcf-yield <GO> |
| Operating Margin | -10.40% | 11.10% | -21.50 | USPH | /operating-margins <GO> |
| Net Profit Margin | -7.90% | 5.10% | -13.00 | USPH | /net-margins <GO> |
| Revenue Growth (YoY) | -1.50% | 16.30% | -17.80 | USPH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.12% | -2.12 | USPH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 2.94 | -2.49 | USPH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | USPH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 79.0 | 52.3 | +26.75 | TDOC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.0x | 27.4x | +4.60 | USPH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.59B | $1.29B | $294.2M | TDOC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TDOC REV | USPH REV | TDOC GROSS % | USPH GROSS % | TDOC FCF | USPH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.53B | $781.0M | — | 19.2% | $285.5M | $75.1M |
| FY 2024 | $2.57B | $671.3M | — | 18.5% | $282.9M | $74.9M |
| FY 2023 | $2.60B | $604.8M | — | — | $232.9M | $82.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TDOC // BETA 1.08
USPH // BETA —